Wed.Mar 06, 2024

article thumbnail

The growing uses of medicinal cannabis

Pharmaceutical Technology

Demand for medicinal cannabis is increasing globally to treat a range of illnesses and conditions.

Medicine 340
article thumbnail

There’s a Surprisingly Simple Way to Remove Microplastics From Your Drinking Water

AuroBlog - Aurous Healthcare Clinical Trials blog

Tiny fragments of microplastics are making their way deep inside our bodies in concerning quantities, significantly through our food and drink. Scientists have now found a simple and effective means of removing them from water.

Scientist 217
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

J&J seeks EU approval for new Darzalex multiple myeloma indication

Pharmaceutical Technology

J&J submitted a new application to the EMA for the approval of its Darzalex combination therapy for multiple myeloma.

246
246
article thumbnail

Regenxbio data suggest ‘niche’ in Duchenne gene therapy

Bio Pharma Dive

Study results showed early signs of promise in Duchenne patients who are currently ineligible to receive Sarepta’s Elevidys, triggering a stock surge.

article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

Sorrento Therapeutics files patent for stable oral liquid pharmaceutical composition of celecoxib for pain relief

Pharmaceutical Technology

Experience rapid pain relief with Sorrento Therapeutics' stable oral liquid pharmaceutical composition of celecoxib. Patent filed for effective pain management within 2 hours.

189
189
article thumbnail

Sionna raises another $182M to challenge Vertex in cystic fibrosis

Bio Pharma Dive

Incubated by RA Capital and backed by a wide array of investors, the startup is developing drugs that work differently than Vertex’s market-leading medicines.

Medicine 183

More Trending

article thumbnail

Gilead bets on ‘trispecifics’ in latest cancer drug deal

Bio Pharma Dive

A small partnership with Merus adds to Gilead’s string of cancer dealmaking, which, so far, has not paid off for the large biotech.

Drugs 188
article thumbnail

Avacta Group files patent for extended circulating serum half-life therapeutic conjugates

Pharmaceutical Technology

Discover Avacta Group's groundbreaking patent for therapeutic conjugates with extended half-life, targeting improved efficacy in treating diseases like cancer. Learn more about this innovative approach now!

147
147
article thumbnail

Alumis, taking aim at Bristol Myers, pulls in $259M for TYK2 drug work

Bio Pharma Dive

The startup, one of a number of young biotechs coming after Bristol Myers’ Sotyktu, will use the cash to fund a late-stage trial in plaque psoriasis.

Drugs 164
article thumbnail

Oncologists encounter parent reluctance for clinical trials of paediatric cancer cases

AuroBlog - Aurous Healthcare Clinical Trials blog

Oncologists during clinical trials of paediatric cancer cases are seen to encounter parent reluctance. Viewed as a significant challenge, cancer care centres have observed that it comes in because of hesitancy by parents to enroll their children.

article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

European VC Invivo readies its latest fund to back new biotechs

Bio Pharma Dive

The Barcelona-based firm, which is targeting about €100 million for the new fund, is eyeing investments in AI, synthetic biology, and cell and gene therapy.

article thumbnail

Navigating Mental Wellness: Understanding Neurodiversity and Self-Kindness

Pharma Mirror

Presented by BetterHelp. In the mental wellness space, neurodiversity can sometimes be overlooked. Although neurodivergent diagnoses differ from mental health concerns, there are often aspects of the diagnosis that can present mental health challenges for some people. For anyone diagnosed with a condition or disorder, self-esteem challenges can arise.

130
130
article thumbnail

Sonrai Analytics and Candel to advance cancer treatment using AI

Pharmaceutical Technology

Sonrai Analytics has entered a partnership with Candel to expedite the development of viral immunotherapies for treating cancer.

article thumbnail

Grand Rounds March 1, 2024: Effect of an Intensive Food-As-Medicine Program on Health and Health Care Use: Evidence from a Randomized Clinical Trial (Joseph Doyle, PhD)

Rethinking Clinical Trials

             Speaker Joseph Doyle, PhD Erwin H. Schell Professor of Management and Applied Economics MIT Sloan School of Management Slides Keywords Food-as-Medicine, Randomized Clinical Trial, Diabetes Key Points Diabetes is common and costly. 9% of the U.S. has the condition; it is responsible for 300,000 premature deaths/year and $330 billion in annual healthcare spending.

article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

Ono signs licence deal with NEX-I for cancer therapy

Pharmaceutical Technology

Ono Pharmaceutical has signed an exclusive licence agreement for the development and marketing of NEX-I’s new cancer therapy, NXI-101.

Marketing 130
article thumbnail

AstraZeneca pledges £650M in UK investments to boost vaccine capabilities, expand near HQ

Fierce Pharma

AstraZeneca CEO Pascal Soriot, who has been critical of the U.K.’s business environment for the life sciences industry, is directing a big chunk of money into the Big Pharma’s home country. | AstraZeneca CEO Pascal Soriot, who has been critical of the U.K.’s business environment for the life sciences industry, is directing £650 million into the Big Pharma’s home country.

article thumbnail

Why small particles matter: Manufacturing and micro-material contamination

Pharmaceutical Technology

To protect patient safety and reduce recall risks, drug manufacturers must reduce particle contamination sources wherever possible.

article thumbnail

GELATIN-Free Medicines: Which Drugs Contain GELATIN?

Drug Patent Watch

GELATIN-Free Medicines, 2024 is part of DrugPatentWatch’s deep library of business intelligence on biopharmaceutical drugs. Buy Gelatin-Free Medicines on Amazon This guide is designed to provide information for healthcare providers to… The post GELATIN-Free Medicines: Which Drugs Contain GELATIN? appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

The New Age of Decentralized Clinical Trials

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

article thumbnail

Akari Therapeutics enters merger deal with Peak Bio

Pharmaceutical Technology

Akari Therapeutics has signed an agreement with Peak Bio to merge in an all-stock transaction, creating a diversified pipeline.

130
130
article thumbnail

UK Chancellor trumpets £650m AstraZeneca investment

pharmaphorum

A £650 million investment package by AstraZeneca in the UK has been held up by Chancellor Jeremy Hunt as a “vote of confidence” in the country’s life sciences sector. AZ is preparing to invest £450 million at its manufacturing site in Speke, Liverpool, to boost research, development and manufacturing of vaccines, including the construction of a new plant that will be powered by renewable energy, according to a government statement.

article thumbnail

FDA approves Sandoz’s two denosumab biosimilars

Pharmaceutical Technology

The US Food and Drug Administration (FDA) has granted approval for Sandoz’s Wyost and Jubbonti, two biosimilars of denosumab.

article thumbnail

Automation of literature search and review

pharmaphorum

Looking to automate your literature search and review process in pharmacovigilance? Learn how AI can streamline the detection and analysis of Adverse Events (AE) effectively.

105
105
article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

Navidea Biopharmaceuticals files patent for polymeric compound for treating diseases involving macrophages

Pharmaceutical Technology

Discover how Navidea Biopharmaceuticals Inc. is revolutionizing targeted drug delivery with a patent for compounds to repolarize tumor-associated macrophages and treat cancer, autoimmune disorders, and infections.

article thumbnail

Women in Science: How curiosity and determination inspired Hayley Crowe's journey from bench to c-suite

BioPharma Reporter

Hayley Crowe is executive vice president and general manager of Ecolabâs Global Life Sciences sector, comprised of Ecolabâs Purolite and pharma / personal care businesses. We sat down with Hayley to discuss how grief inspired her determination to make a difference and how she is helping female colleagues address their imposter syndrome and 'mental attack'.

article thumbnail

Kalvista Pharmaceuticals files patent for treatment of bradykinin-mediated angioedema with oral plasma kallikrein inhibitor

Pharmaceutical Technology

Discover Kalvista Pharmaceuticals' innovative patent for on-demand treatment of bradykinin-mediated angioedema with an orally administered plasma kallikrein inhibitor. Providing easier options for patients struggling with tablet swallowing.

100
100
article thumbnail

12 Questions with Jorge Reis-Filho

pharmaphorum

Get to know Jorge Reis-Filho, Vice President of Cancer Biomarker Development at AstraZeneca, through this exclusive interview featuring 12 insightful questions. Gain insights into his role, career journey, and the latest advancements in cancer biomarker development.

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Amarin Corp files patent for pharmaceutical composition for treating carious diseases and disorders

Pharmaceutical Technology

Discover Amarin Corp's groundbreaking patent for EPA and statin compositions to treat cardiovascular diseases. Learn about the innovative method and solid dosage forms outlined in the patent for optimal treatment outcomes.

100
100
article thumbnail

How Long Will the Current Slowdown in Biotech Investment Last?

Pharmaceutical Commerce

In this Pharmaceutical Commerce video interview, Emma Banks, CEO of ramarketing, discusses how the balance between onshoring and outsourcing will evolve, how long will the current slowdown in biotech investment likely last, and what factors might influence its duration.

105
105
article thumbnail

PTC Therapeutics files patent for pharmaceutical composition for treating various diseases

Pharmaceutical Technology

Discover the innovative pharmaceutical composition patented by PTC Therapeutics Inc. to treat diseases like a-synucleinpathy and liver diseases. Learn about the specific ratios of ingredients and administration methods outlined in the patent.

100
100
article thumbnail

ClinOne's enhanced self-service platform empowers users like never before

Outsourcing Pharma

ClinOne, a leading provider of clinical trial technology, has unveiled what it calls a major enhancement to its platform, offering customers far more control and flexibility.

article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.